Asset

  • No.

    78

  • Asset Title

    Matriptase_OA and Inflammatory diseases

  • Organization

    LifeArc

  • Product Type

    Small molecule

  • Therapeutic Area

    Orthopedics

  • Development Stage

    Hit To Lead or Lead Optimization

  • Technical Summary

    • An effective ‘disease-modifying OA drug’ would target a detrimental protein present in an OA joint but not the normal joint

     

    • Our research has enabled the validation of matriptase as a therapeutic target for osteoarthritis

  • Researcher

  • Patent

  • Publication

  • Attachment

    LifeArc_Overview_Matriptase_OA and Inflammatory diseases.pdf
    LifeArc_Slide deck_Matriptase.pdf

TOP